Cellectis S.A.
CLLSHealthcare|Biotechnology|FR
$1.07
+0.04 (+3.88%)
Tangible Book / Share
$0.40
Cash / Share
$1.66
Ownership Breakdown
85.3%
Float
100.7M
Shares Outstanding
85.9M
Float Shares
Major Holders (12)
Combined: 146.1%
Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.
| Holder | Type | % of Class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| AstraZeneca PLC | Corporation | 44.00% | 44,000,000 | Jan 24, 2025 | 13D/G |
| AstraZeneca Holdings B.V. | Corporation | 44.00% | 44,000,000 | Jan 24, 2025 | 13D/G |
| Caisse des Depots | Other | 11.10% | 10,599,440 | Dec 12, 2025 | 13D/G |
| Bpifrance Participations S.A. | Other | 10.00% | 9,559,534 | Dec 12, 2025 | 13D/G |
| Bpifrance S.A. | Other | 10.00% | 9,559,534 | Dec 12, 2025 | 13D/G |
| EPIC Bpifrance | Other | 10.00% | 9,559,534 | Dec 12, 2025 | 13D/G |
| John Helmers | Individual | 4.60% | 4,617,293 | Feb 11, 2025 | 13D/G |
| Long Focus Capital Management, LLC | Investment adviser | 4.60% | 4,617,293 | Feb 11, 2025 | 13D/G |
| Long Focus Capital Master, LTD. | Non-US institution | 2.50% | 2,510,101 | Feb 11, 2025 | 13D/G |
| Glenn Helmers | Individual | 2.10% | 2,107,192 | Feb 11, 2025 | 13D/G |
| Condagua, LLC | Other | 2.10% | 2,107,192 | Feb 11, 2025 | 13D/G |
| CDC Croissance S.A. | Other | 1.10% | 1,039,906 | Dec 12, 2025 | 13D/G |